Please Wait
Applying Filters...
menu
    • menu
    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Virtual Booth

    Contact Supplier

    Aspen API. More than just an API™

    Virtual Booth

    Contact Supplier

    jdmfs-not-supported-m-2025-04-28

    Virtual Booth

    An Enquiry

    Menu

    Sarconeos

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    DIGITAL CONTENT

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Biophytis Announces Successful BIO101 Indus. trial Transfer To Seqens
    Biophytis Announces Successful BIO101 Indus. trial Transfer To Seqens

    12 Jun 2024

    // PRESS RELEASE

    https://www.biophytis.com/en/biophytis-announces-the-successful-industrial-transfer-of-bio101-20-hydroxyecdysone-production-by-its-service-provider-seqens/

    PRESS RELEASE
    12 Jun 2024
    Share Share
    Biophytis has Requested Pre-Submission Meeting with FDA for EUA of Sarconeos
    Biophytis has Requested Pre-Submission Meeting with FDA for EUA of Sarconeos

    20 Jul 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=769306&lang=en

    ACCESSWIRE
    20 Jul 2023
    Share Share
    Biophytis has Filed with the HAS an Application for EAA for Sarconeos
    Biophytis has Filed with the HAS an Application for EAA for Sarconeos

    26 May 2023

    // ACCESSWIRE

    https://www.accesswire.com/viewarticle.aspx?id=757514&lang=en

    ACCESSWIRE
    26 May 2023
    Share Share